Novocure (NVCR) traded down -3.08 % during a 24 hours period ending at 06:42 AM Central Europe on Friday 30th. One Novocure stock can currently be bought for about USD 13.11 on popular exchanges. Current supply of Novocure stocks is 116.4 mn. Novocure has a current market capitalization of USD 1.7 bn and approximately USD 33.8 mn worth of Novocure was traded on exchanges in the last 24 hours. Since last month end, Novocure has traded -11.38 % down. Simple moving average of last 200 days is at USD 14.82. The highest price of past 52 weeks was recorded at USD 21.45 on 07/24/2026. 52 weeks low was at USD 9.82 on 02/09/2026.
Here is how related stocks have performed in the past 24 hours:
Royal Road Minerals (RYR.V) traded flat 0 % and now trades at CAD 0.2. Current market capitalisation for Royal Road Minerals is CAD 47.9 mn.
Chenavari Toro Income L (TORO.L) traded up 0.95 % and now trades at EUR 0.52. Current market capitalisation for Chenavari Toro Income L is EUR 184.3 mn.
Rosebank Industries (ROSE.L) traded flat 0 % and now trades at GBX 322. Current market capitalisation for Rosebank Industries is GBX 4.2 bn.
Srj (SRJ.AX) traded flat 0 % and now trades at AUD 0.01. Current market capitalisation for Srj is AUD 7 mn.
Grandstand (6WH.F) traded down -7.19 % and now trades at EUR 0.99. Current market capitalisation for Grandstand is EUR 35.2 mn.
About Novocure
Novocure Limited is a health care company that specializes in oncology, or the treatment of cancer. The company researches and develops novel technologies for this purpose. As a global health care equipment and supply company, Novocure serves the industry worldwide. You can find more information about their work on their website, www.novocure.com , and they are listed on the Nasdaq stock exchange. Their initial public offering (IPO) date was October 2nd, 2015.